Research consortium offers new hope for Parkinson's disease. Issue 6 (June 2016) - Buckland, Danny
Abstract : Until recently, research progress in the field of Parkinson's disease has been slow compared with other therapeutic areas. However, a new consortium of pharmaceutical companies, academic researchers and charities – the Critical Path for Parkinson's Consortium – is helping to accelerate the development of new treatments to slow disease progression.